Document is current
Any future updates will be listed below
-
Authors
Flores, Bianca C. T. http://orcid.org/0000-0002-6490-6309
Chawla, Smriti
Ma, Ning
Sanada, Chad
Kujur, Praveen Kumar
Yeung, Rudy
Bellon, Margot B. http://orcid.org/0000-0002-0040-2523
Hukari, Kyle
Fowler, Brian
Lynch, Mark
Chinen, Ludmilla T. D.
Ramalingam, Naveen
Sengupta, Debarka http://orcid.org/0000-0002-6353-5411
Jeffrey, Stefanie S. http://orcid.org/0000-0003-4478-2764
- License Information
-
More Information
Article History
Received: 3 December 2021
Accepted: 1 November 2022
First Online: 12 November 2022
Competing interests
: K.H. and N.R. are employees and stockholders of Fluidigm Corporation. M.L. is a former employee and stockholder of Fluidigm Corporation. D.S. is a stockholder of CareOnco Biotech Pvt. Ltd. and GenterpretR Inc. S.S.J. serves as a scientific advisor for Quantumcyte and Ravel Biotechnology. D.S. is an Editorial Board Member for <i>Communications Biology</i>, but was not involved in the editorial review of, nor the decision to publish this article.
